Zuellig
Roche

ROCHE DIAGNOSTICS GMBH

Featured products of Roche Diagnostics
obinutuzumab
Packing/Price
50 mL x 1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01XC15 - obinutuzumab : Belongs to the class of monoclonal antibodies, other antineoplastic agents. Used in the treatment of cancer.
Distributed by Zuellig
obinutuzumab
Packing/Price
50 mL x 1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01XC15 - obinutuzumab : Belongs to the class of monoclonal antibodies, other antineoplastic agents. Used in the treatment of cancer.
Marketed by Roche
obinutuzumab
Packing/Price
50 mL x 1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01XC15 - obinutuzumab : Belongs to the class of monoclonal antibodies, other antineoplastic agents. Used in the treatment of cancer.

Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in